Achilles Therapeutics (NASDAQ:ACHL) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Achilles Therapeutics (ACHL) operate in?

Achilles Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Achilles Therapeutics Stock (NASDAQ: ACHL) stock price, news, charts, stock research, profile.

Open	$1.39
Close	-
Volume / Avg.	29.97K / 754.78K
Day Range	$1.38 - $1.39
52 Wk Range	0.63 - 1.76
Market Cap	$59.15M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	73
Short Interest	0.22%
Days to Cover	1

Recent News

Achilles Therapeutics Announces $12M AstraZeneca Deal, Plans Job Cuts

Achilles Therapeutics announces a $12M deal with AstraZeneca for TRACERx data and plans job cuts following its strategic review.

Nabaparna Bhattacharya

Achilles Therapeutics Shares Are Trading Higher: What You Need To Know

Shares of Achilles Therapeutics plc (NASDAQ: ACHL) are surging following a major strategic announcement from the company. The biotechnology firm revealed plans to discontinue its TIL-based cNeT program and close its ongoing Phase I/IIa clinical trials, CHIRON and THETIS.

Vaishali Prayag

Dow Dips Over 200 Points; RPM International Shares Fall After Q3 Results

U.S. stocks turned lower toward the end of trading, with the Dow Jones index falling more than 200 points on Thursday. The Dow traded down 0.59% to 38,894.58 while the NASDAQ fell 0.10% to 16,261.88. The S&P 500 also fell, dropping, 0.28% to 5,197.03.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Rating and Forecast

2.3

Sell

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$1.39
Close	-
Volume / Avg.	29.97K / 754.78K
Day Range	$1.38 - $1.39
52 Wk Range	0.63 - 1.76
Market Cap	$59.15M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	73
Short Interest	0.22%
Days to Cover	1

About Achilles Therapeutics Plc

Sector

Health Care

Industry

Biotechnology

Achilles Therapeutics PLC is a biopharmaceutical company. It is developing AI-powered precision T-ce...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Achilles Therapeutics (ACHL) stock?

You can purchase shares of Achilles Therapeutics (NASDAQ:ACHL) through any online brokerage.

View our list of the best stock brokerages

Who are Achilles Therapeutics (ACHL) competitors?

Other companies in Achilles Therapeutics’s space includes: Outlook Therapeutics (NASDAQ:OTLK), CytomX Therapeutics (NASDAQ:CTMX), Estrella Immunopharma (NASDAQ:ESLA), Gain Therapeutics (NASDAQ:GANX) and Connect Biopharma Hldgs (NASDAQ:CNTB).

What is the forecast, or price target, for Achilles Therapeutics (ACHL) stock?

Achilles Therapeutics has a consensus price target of $2.83.

What is the current price for Achilles Therapeutics (ACHL)?

The stock price for Achilles Therapeutics (NASDAQ: ACHL) is $1.385 last updated February 24, 2025 at 11:08 AM EST.

Does Achilles Therapeutics (ACHL) pay a dividend?

There are no upcoming dividends for Achilles Therapeutics.

When is Achilles Therapeutics (NASDAQ:ACHL) reporting earnings?

Achilles Therapeutics’s Q1 earnings are confirmed for Wednesday, May 7, 2025.

Is Achilles Therapeutics (ACHL) going to split?

There is no upcoming split for Achilles Therapeutics.

What sector and industry does Achilles Therapeutics (ACHL) operate in?

Achilles Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Achilles Therapeutics

Achilles Therapeutics (ACHL) Forecast